Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Bayer plc, 400 South Oak Way, Reading, RG2 6AD
Microgynon 30.
Pharmaceutical Form |
---|
Sugar-coated tablets. Each tablet is beige. |
Each tablet contains:
Actives:
Levonorgestrel: 150 mcg
Ethinylestradiol: 30 mcg
Excipients:
Lactose: 32.820 mg
Sucrose: 19.371 mg
For full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
17 alpha-Ethinylestradiol |
Ethinylestradiol is chemically and biologically identical to endogenous human oestradiol. It substitutes for the loss of estrogen production in menopausal women, and alleviates menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy. |
|
Levonorgestrel |
The precise mode of action of levonorgestrel as an emergency contraceptive is not known. At the recommended regimen, levonorgestrel is thought to work mainly by preventing ovulation and fertilisation if intercourse has taken place in the preovulatory phase, when the likelihood of fertilisation is the highest. |
List of Excipients |
---|
Each tablet contains: Core: Lactose monohydrate Coating: Sucrose |
Deep drawn strips made of polyvinyl chloride film with counter-sealing foil made of aluminium with heat sealable coating.
Presentation: Each carton contains either 1, 3 or 50 blister memo-packs. Each blister memo-pack contains 21 tablets.
Bayer plc, 400 South Oak Way, Reading, RG2 6AD
PL 00010/0545
Date of First Authorisation: 28 November 1973
Date of Renewal: 5 December 2008
Drug | Countries | |
---|---|---|
MICROGYNON | Austria, Australia, Ecuador, Spain, Hong Kong, Israel, Malta, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.